TITLE:
Safety and Efficacy of Aliskiren When Added to Standardized Losartan and Optimal Antihypertensive Therapy in Patients With Hypertension, Type 2 Diabetes and Proteinuria

CONDITION:
Diabetic Nephropathy

INTERVENTION:
aliskiren

SUMMARY:

      Study of the efficacy and safety of aliskiren when added to losartan and optimal
      antihypertensive therapy in patients with hypertension, type 2 diabetes, and kidney
      disorders to monitor improvement in any of these conditions.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 80 Years
Criteria:

        Inclusion Criteria:

          -  Hypertension

          -  Elevated urinary protein levels

          -  Confirmed type 2 diabetes

        Exclusion Criteria:

          -  Certain diseases

          -  Uncontrolled diabetes

          -  Type 1 diabetes
      
